ClinicalTrials.Veeva

Menu

Use of Dexamethasone in Uterine Artery Embolization

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Uterine Myoma
Adenomyosis

Treatments

Drug: Normal saline
Drug: Dexamethasone

Study type

Interventional

Funder types

Other

Identifiers

NCT02056717
4-2013-0863

Details and patient eligibility

About

The primary purpose of this study is to investigate the effects of dexamethasone on inflammatory reactions after uterine artery embolization. The secondary purpose of this study it to investigate the effects of dexamethasone on postembolization syndrome (severe pain, nasea and vomiting).

Enrollment

64 patients

Sex

Female

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Uterine artery embolization due to multiple myoma or adenomyosis

Exclusion criteria

  • Diabetic mellitus
  • Steroid administration
  • Liver or kidney dysfuntion
  • High baseline CRP or leukocytosis (>11,000/μL )
  • Drug allergy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

64 participants in 2 patient groups, including a placebo group

Dexamethasone group
Experimental group
Treatment:
Drug: Dexamethasone
Control group
Placebo Comparator group
Treatment:
Drug: Normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems